• Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review

    9 days ago - By Pediatric Rheumatology

    Rapidly progressive interstitial lung disease is a life-threatening complication of juvenile dermatomyositis ; however, it is generally refractory to treatment; to the best of our knowledge, no...
    Read more ...